A bioanalytical company offering sample analysis in plasma, tissue samples and urine – fully compliant to OECD GLP and other relevant guidelines.
Out team consists of 8 dedicated analysis chemists what aim for fast and high-quality delivers that fits your needs. We specialise in bioanalysis in the preclinical and clinical stage of your drug development.
Lablytica is part of the Swedish OECD GLP program. The last OECD GLP inspection of Lablytica was performed in November 2020.
Lablytica is regularly inspected by SWEDAC, who is the regulatory body performing OECD GLP inspections of laboratories in Sweden.